Boltz raises $110M Series A for AI biomolecular design, partners with 6 of top 20 pharmas

GabriCorso · x · 2026-11-19

AI biomolecular design startup Boltz announced a $110M Series A led by Bessemer Venture Partners.

Key numbers:

Boltz aims to bring AI-powered biomolecular design to every scientist.

Related event: AI drug design firm Boltz raises $110M Series A as molecular token usage jumps 50x(41 posts)→

Original post →

More from Venture

Venture channel →